Product Information
QUETIAPINE ER 400 MG TABLET is a generic product labeled by Ingenus Pharmaceuticals LLC, priced at $0.3194 per EA under NDC 50742063960. Its NADAC has been published 380 times since Dec 27, 2017.
FDA first approved this application on Nov 29, 2017. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the quetiapine fumarate market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
400 mg/1
Manufacturer
Ingenus Pharmaceuticals LLCNDC
50742063960
Classification
Generic
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Effective Date
3/19/2025
Active Ingredients
QUETIAPINE FUMARATEApproval Type
Generic (ANDA)
FDA Application
ANDA208947FDA Approved
11/29/2017
TE Code
AB
On Market Since
8/31/2017
Pharmacological Classes
Price Statistics
The NADAC for QUETIAPINE ER 400 MG TABLET has been published 380 times since Dec 27, 2017, and over the history we have for it it has declined 75.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3194 per EA |
|---|---|
| All-time high | $1.3114 (Jan 10, 2018) |
| All-time low | $0.2506 (Jul 17, 2024) |
| Median price | $0.5147 |
| Average price | $0.5362 |
| Largest weekly change | +47.1% (Aug 21, 2024) |
| Weeks tracked | 380 |
| Tracking since | Dec 27, 2017 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
-32.9%
5Y
-39.8%
All
-75.6%
Last surveyed Apr 2, 2025 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 52% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of QUETIAPINE ER 400 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for QUETIAPINE ER 400 MG TABLET, manufactured by Ingenus Pharmaceuticals LLC, is $0.3194 per EA (NDC 50742063960), effective Apr 2, 2025.
How has the price of QUETIAPINE ER 400 MG TABLET changed over time?
Over the history we have for it, the NADAC for QUETIAPINE ER 400 MG TABLET has declined 75.6%. It has been tracked across 380 weekly CMS publications since Dec 27, 2017.
What are the highest and lowest recorded NADAC prices for QUETIAPINE ER 400 MG TABLET?
Since Dec 27, 2017, the NADAC for QUETIAPINE ER 400 MG TABLET has ranged from a low of $0.2506 (Jul 17, 2024) to a high of $1.3114 (Jan 10, 2018), with a median of $0.5147 per EA.
Are there cheaper alternatives to QUETIAPINE ER 400 MG TABLET?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, QUETIAPINE FUMARATE 400 MG TAB, is $0.1548 per EA — about 52% below QUETIAPINE ER 400 MG TABLET.
Who manufactures QUETIAPINE ER 400 MG TABLET?
QUETIAPINE ER 400 MG TABLET (NDC 50742063960) is labeled by Ingenus Pharmaceuticals LLC, and CMS classifies it as a generic product.